Literature DB >> 15160978

Dyspepsia in African-American and Hispanic patients.

Abbasi J Akhtar1, Magda A Shaheen.   

Abstract

Dyspepsia is a common disorder with a prevalence of up to 40% in the general population. The presence of alarm features (age >50 years, loss of appetite, early satiety, loss of weight, dysphagia, abdominal mass, gastrointestinal bleeding, and/or anemia) increase the likelihood of an organic etiology. Despite a plethora of information written on this subject, the literature is sparse in minority populations. We studied the etiology of dyspepsia in relation to age and the presence or absence of alarm features in 678 African-American and Hispanic patients. Five-hundred-thirty patients were investigated by upper gastrointestinal (UGI) endoscopy, 88 by barium radiographs of the UGI tract, and 60 patients had both endoscopy and barium studies. The most common alarm feature in our study was age >50 years, followed by anemia, weight loss, gastrointestinal bleeding, loss of appetite, early satiety, abdominal mass, and dysphagia. The presence of alarm features and older age increased the likelihood of finding an organic lesion. It is concluded, therefore, that endoscopy in our dyspeptic patients who had alarm features appears to increase the diagnostic yield and may consequently result in a more favorable therapeutic outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15160978      PMCID: PMC2640656     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  30 in total

1.  Accuracy of provisional diagnoses of dyspepsia in patients undergoing first endoscopy.

Authors:  J I Westbrook; J H McIntosh; J M Duggan
Journal:  Gastrointest Endosc       Date:  2001-03       Impact factor: 9.427

2.  There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia.

Authors:  S Bruley Des Varannes; J F Fléjou; R Colin; M Zaïm; A Meunier; C Bidaut-Mazel
Journal:  Aliment Pharmacol Ther       Date:  2001-08       Impact factor: 8.171

3.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

4.  Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.

Authors:  J Koskenpato; M Farkkilä; P Sipponen
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

5.  Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care.

Authors:  B C Delaney; S Wilson; A Roalfe; L Roberts; V Redman; A Wearn; A Briggs; F D Hobbs
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

Review 6.  The value of alarm features in identifying organic causes of dyspepsia.

Authors:  L G Madsen; P Bytzer
Journal:  Can J Gastroenterol       Date:  2000-09       Impact factor: 3.522

Review 7.  Nonulcer dyspepsia: what it is and what it is not.

Authors:  G R Locke
Journal:  Mayo Clin Proc       Date:  1999-10       Impact factor: 7.616

8.  Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States.

Authors:  J E Everhart; D Kruszon-Moran; G I Perez-Perez; T S Tralka; G McQuillan
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

9.  Upper gastrointestinal hemorrhage in African-American and Hispanic elderly patients.

Authors:  A J Akhtar; K Ganesan; T T Yoshikawa
Journal:  Ethn Dis       Date:  2001       Impact factor: 1.847

Review 10.  Lower gastrointestinal hemorrhage in African-American and Hispanic elderly patients.

Authors:  Abbasi J Akhtar
Journal:  Ethn Dis       Date:  2002       Impact factor: 1.847

View more
  1 in total

1.  Influence of various factors on functional dyspepsia.

Authors:  Barbara Ebling; Dragan Jurcic; Karolina Majstorovic Barac; Ante Bilic; Iva Bajic; Miran Martinac; Sandra Pribic; Aleksandar Vcev
Journal:  Wien Klin Wochenschr       Date:  2015-04-14       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.